Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gilead-Backed Kyverna Overshoots Raised IPO Expectations By: TalkMarkets February 11, 2024 at 14:20 PM EST Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a drug developer this year. Read More >> Related Stocks: AHR Gilead Sciences Helix Acquisition Corp. II - Class A Ordinary Shares Kyverna Therapeutics, Inc. - Common Stock Metagenomi, Inc. - Common Stock PMNT TBBB Telomir Pharmaceuticals, Inc. - Common Stock Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Gilead-Backed Kyverna Overshoots Raised IPO Expectations By: TalkMarkets February 11, 2024 at 14:20 PM EST Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a drug developer this year. Read More >> Related Stocks: AHR Gilead Sciences Helix Acquisition Corp. II - Class A Ordinary Shares Kyverna Therapeutics, Inc. - Common Stock Metagenomi, Inc. - Common Stock PMNT TBBB Telomir Pharmaceuticals, Inc. - Common Stock
